INS and prostate carcinoma: For example, one study showed that men with type 2 diabetes, both not on medication and on insulin, have increased prostate cancer mortality, suggesting that a poorly controlled metabolic state of diabetes may contribute to prostate cancer progression and disease aggressiveness [28].